The World Health Organization (WHO) has issued a global alert regarding the presence of fake Ozempic, a medication primarily used to treat type-2 diabetes but has gained popularity as a weight-loss aid. The fake versions of the drug, also known as a "skinny jab," have raised concerns about potential health risks.
The active ingredient in Ozempic, semaglutide, not only helps control blood sugar levels in people with diabetes but also signals to the brain that the individual is full, thus reducing the urge to eat and aiding in weight loss. However, individuals without diabetes have been seeking out the drug for its weight-loss benefits, leading to shortages for those who actually need it for medical reasons.
Reports of counterfeit Ozempic have been on the rise since 2022, with fake batches being seized in various countries including the UK, US, and Brazil. The WHO has warned healthcare professionals, regulatory authorities, and the public to be cautious and only obtain the medication from reputable sources like doctors, rather than purchasing it from obscure online sites or social media platforms.
The fake Ozempic injections may not contain semaglutide at all, or they may contain other medications such as insulin, which could have unpredictable and harmful effects on individuals' health. The UK's drugs regulator has also identified fake Ozempic pens that appeared to have authentic packaging but were found to be illegitimate.
In light of these issues, the WHO and health authorities are urging individuals to be vigilant and avoid purchasing medications from unauthorized sources. It is essential to prioritize safety and ensure that the medications being used are legitimate and obtained through proper channels to prevent any potential health risks associated with fake drugs.